Citius Oncology, Inc. (CTOR) vs Neonc Technologies Holdings, Inc. (NTHI)

A side-by-side comparison of Citius Oncology, Inc. and Neonc Technologies Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Citius Oncology, Inc. logo
CTOR
Citius Oncology, Inc.
$78M
$0.84HealthcareDelayed quote: Oct 6, 2026, 3:19 PM EDT
Neonc Technologies Holdings, Inc. logo
NTHI
Neonc Technologies Holdings, Inc.
$77M
$2.98HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT

Total return — CTOR vs NTHI

growth of $100 · dividends reinvested · last 1y
CTOR +27.7% (+27.7%/yr)NTHI -69.7% (-69.7%/yr)CTOR compounded faster over this window
0200400600800Start $1002026$128$30
CTOR NTHI

CTOR vs NTHI: by the numbers

  • •CTOR is the larger company ($78M vs $77M market cap).
  • •Both run net losses; CTOR's is the smaller (-648.32% vs -155404.38% net margin).

Metrics side by side

Valuation

MetricCTORNTHI
Forward P/E8.37N/A
P/S ratio10.95N/A
P/B ratio1.93N/A

Profitability

MetricCTORNTHI
Gross margin0.00%100.00%
Operating margin0.00%-145459.36%
Net margin-648.32%-155404.38%
ROE-114.06%N/A
ROIC-88.72%N/A

Go deeper

Full CTOR analysisFull NTHI analysisInteractive comparison tool

Dig into the metrics

Citius Oncology ROENeonc Technologies ROECitius Oncology operating marginNeonc Technologies operating marginCitius Oncology revenue growthNeonc Technologies revenue growthCitius Oncology free cash flowNeonc Technologies free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.